Neurizon Therapeutics Limited Is A Clinical Stage Biotechnology Company Based In South Melbournevictoriaaustraliaformerly Known As Pharmaust Limitedthe Company Focuses On Developing Innovative Treatments For Neurodegenerative Diseasesneurizon Is Publicly Listed On The Australian Stock Exchange Under The Ticker Symbol Nuz Ax And Operates Internationallywith Activities In Switzerlandthe United Statesand Other Regions The Company S Lead Productnuz 001S Monepantel Is A Small Molecule Mtor Inhibitor Designed To Activate Autophagy In Neuronal Cellsit Is Being Developed For The Treatment Of Various Neurodegenerative Diseasesincluding Amyotrophic Lateral Sclerosisals Alzheimer S Diseaseand Parkinson S Diseaseneurizon Has Plans For A Phase Ii Iii Clinical Trial For Alsset To Begin In 2025And Is Also Advancing Pre Clinical Programs For Alzheimer S And Parkinson S Diseases
No conferences found for this company.
| Company Name | Pharmaust Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
